scholarly journals Clinical Analysis of Risk Factors Related to Recurrent Chronic Subdural Hematoma

2008 ◽  
Vol 43 (1) ◽  
pp. 11 ◽  
Author(s):  
Byung-Soo Ko ◽  
Jung-Kil Lee ◽  
Bo-Ra Seo ◽  
Sung-Jun Moon ◽  
Jae-Hyoo Kim ◽  
...  
Keyword(s):  
Risk Factors ◽  
Subdural Hematoma ◽  
Chronic Subdural Hematoma ◽  
Clinical Analysis

A Clinical Analysis in Risk Factors of Chronic Subdural Hematoma: Focusing on the Age

2012 ◽  
Vol 8 (2) ◽  
pp. 115 ◽  
Author(s):  
Yang-Won Sim ◽  
Kyung-Soo Min ◽  
Mou-Seop Lee ◽  
Young-Gyu Kim ◽  
Dong-Ho Kim
Keyword(s):  
Risk Factors ◽  
Subdural Hematoma ◽  
Chronic Subdural Hematoma ◽  
Clinical Analysis

Clinical Analysis of Risk Factors Associated with the Recurrence of Chronic Subdural Hematoma

2011 ◽  
Vol 7 (2) ◽  
pp. 68 ◽  
Author(s):  
Sung Yong Ahn ◽  
Jong Hyun Kim ◽  
Sung Kohn Ha ◽  
Joo Han Kim ◽  
Taek Hyun Kwon ◽  
...  
Keyword(s):  
Risk Factors ◽  
Subdural Hematoma ◽  
Chronic Subdural Hematoma ◽  
Clinical Analysis ◽  
Factors Associated

Recurrent Chronic Subdural Hematoma: Clinical and Imaging Risk Factors

2018 ◽  
Vol 15 (01) ◽  
pp. 008-015 ◽  
Author(s):  
Benaissa Abdennebi ◽  
Maher Al Shamiri
Keyword(s):  
Risk Factors ◽  
Subdural Hematoma ◽  
Heart Diseases ◽  
Chronic Subdural Hematoma ◽  
Antiplatelet Agents ◽  
The Elderly ◽  
Imaging Data ◽  
Anticoagulation Agents ◽  
The Right ◽  
Recurrence Group

Abstract Background Chronic subdural hematoma (CSDH) is a major cause of neurosurgical emergencies in the elderly. Despite the use of routine surgical practices, recurrence of this condition is expected. This study was conducted to identify the risk factors (RF) for recurrent CSDH. Methods Between January 2016 and July 2017, 103 consecutive patients suffering from CSDH were admitted to our department. The no-recurrence group (NRG) consisted of 91 patients, and the recurrence group (RG) consisted of 12 patients. To identify the RF involved in recurrent CSDH, we analyzed multiple factors, including patient comorbidities and imaging data. Results Between the two groups, there were no statistical differences (p > 0.05) for head trauma, diabetes mellitus (DM), high blood pressure, heart diseases, anticoagulation agents, or seizures; however, DM was associated with one of the above-mentioned factors. In contrast, there were significant differences for antiplatelet agents (APA) (p < 10–6) and the right side of the hematoma location (p = 0.03). Conclusion Although the literature highlights the controversy regarding RF for CSDH, we detected APA and the right side as RF, whereas DM alone or associated with another comorbidity does not affect the CSDH outcome.

The risk factors for recurrence of chronic subdural hematoma

2012 ◽  
Vol 36 (1) ◽  
pp. 145-150 ◽  
Author(s):  
Shigeo Ohba ◽  
Yu Kinoshita ◽  
Toru Nakagawa ◽  
Hideki Murakami
Keyword(s):  
Risk Factors ◽  
Subdural Hematoma ◽  
Chronic Subdural Hematoma ◽  
Risk Factors For Recurrence

scholarly journals Prediction of Risk Factors for the Evolution of Traumatic Subdural Effusion into Chronic Subdural Hematoma

2020 ◽  
Vol Volume 16 ◽  
pp. 943-948
Author(s):  
Sansong Chen ◽  
Hui Peng ◽  
Xuefei Shao ◽  
Lin Yao ◽  
Jie Liu ◽  
...  
Keyword(s):  
Risk Factors ◽  
Subdural Hematoma ◽  
Chronic Subdural Hematoma ◽  
Subdural Effusion

Frequency of and Risk Factors for Chronification in Traumatic Acute Subdural Hematoma following Conservative Therapy

2019 ◽  
Vol 80 (05) ◽  
pp. 359-364 ◽  
Author(s):  
Stefanie Kaestner ◽  
Marina van den Boom ◽  
Wolfgang Deinsberger
Keyword(s):  
Risk Factors ◽  
Subdural Hematoma ◽  
Head Injuries ◽  
Chronic Subdural Hematoma ◽  
Length Of Hospital Stay ◽  
The Elderly ◽  
Coagulation System ◽  
Acute Subdural Hematoma ◽  
Neurosurgical Department ◽  
Anticoagulant Medication

Background In an aging society, traumatic head injuries, such as acute subdural hematomas (aSDHs), are increasingly common because the elderly are prone to falls and are often undergoing anticoagulation treatment. Especially in advanced age, cranial surgery such as craniotomies may put patients in further jeopardy. But if treatment is conservative, a chronic subdural hematoma (cSDH) may develop, requiring surgical evacuation. Existing studies have reported a correlation between several risk factors contributing to the frequency of chronification. To improve the prediction of the course of disease and to aid counseling patients and relatives, this study aimed to determine the frequency and the main risk factors influencing the process of chronification of an aSDH following conservative treatment. Methods We identified patients presenting between January 2012 and September 2017 at our neurosurgical department with an aSDH. All patients treated conservatively were selected retrospectively, and the following parameters were documented: age, sex, chronification status, Glasgow Coma Scale score on admission and discharge, hematoma thickness and density, the degree of midline shift (MLS), prior anticoagulants and administration of procoagulants, thrombosis management, other coagulopathies, initial length of hospital stay, interval between discharge and readmission, and interval between initial injury and date of surgery and last follow-up. The cohort was divided into patients with complete resolution of their aSDH, and patients who needed surgery due to chronification. Results A total of 75 conservatively treated patients with aSDH were included. A chronification was observed in 24 cases (32%). The process of chronification takes an average of 18 days (range: 10–98 days). The following factors were significantly associated with the process of chronification: age (p = 0.001), anticoagulant medication (acetylsalicylic acid [ASA], Coumadin, and novel anticoagulants [NOACs]) before injury (p = 0.026), administration of procoagulants (p = 0.001), presence of other coagulopathies such as thrombocytopenia (p = 0.002), low hematoma density at discharge (p = 0.001), hematoma thickness on admission and discharge (p = 0.001), and the degree of MLS (p = 0.044). Conclusion Chronification occurred in a third of all patients with conservatively treated aSDH, on average within 3 weeks. The probability of developing a cSDH is 0.96 times higher with every yearly increase in age, resulting in 56% chronification in patients ≥ 70 years. Hematoma thickness and impairment of the coagulation system such as anticoagulant medication (ASA, Coumadin, and NOACs) or thrombocytopenia are further risk factors for chronification.

Clinical Analysis of Chronic Subdural Hematoma Developed from Traumatic Subdural Hygroma in the Eldery

2007 ◽  
Vol 3 (1) ◽  
pp. 8
Author(s):  
Seok-Won Chung ◽  
Jin-Woo Park ◽  
Seong-Hyun Park ◽  
Jaechan Park ◽  
Sung-Kyoo Hwang ◽  
...  
Keyword(s):  
Subdural Hematoma ◽  
Chronic Subdural Hematoma ◽  
Clinical Analysis ◽  
Subdural Hygroma
Sign in / Sign up

Export Citation Format

Share Document